» Articles » PMID: 22088788

Long-term Follow-up of Patients with Congenital Myasthenic Syndrome Caused by COLQ Mutations

Overview
Specialty Neurology
Date 2011 Nov 18
PMID 22088788
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Congenital myasthenic syndromes (CMS) are clinically and genetically heterogeneous inherited disorders characterized by impaired neuromuscular transmission. Mutations in the acetylcholinesterase (AChE) collagen-like tail subunit gene (COlQ) cause recessive forms of synaptic CMS with end plate AChE deficiency. We present data on 15 COLQ -mutant CMS carrying 16 different mutations (9 novel ones identified) followed-up for an average period of 10 ears. The mean age at the first examination was 19 ears old (range from 3 to 48). We report relapses during short or long-term periods characterized by worsening of muscle weakness sometimes associated with respiratory crises. All the relapses ended spontaneously or with 3-4 DAP or ephedrine with no residual impairment. The triggering factors identified were esterase inhibitors, effort, puberty or pregnancy highlighting the importance of hormonal factors. There was no genotype-phenotype correlation. At the end of the follow-up, 80% of patients were ambulant and 87% of patients had no respiratory trouble in spite of severe relapses.

Citing Articles

An α7 nicotinic and GABA receptor-mediated pathway controls acetylcholine release in the tripartite neuromuscular junction.

Petrov K, Lenina O, Leroy J, Bernard V, Germain T, Truong C J Physiol. 2024; 603(2):507-527.

PMID: 39740234 PMC: 11737540. DOI: 10.1113/JP287243.


Congenital myasthenic syndromes in adults: clinical features, diagnosis and long-term prognosis.

Theuriet J, Masingue M, Behin A, Ferreiro A, Bassez G, Jaubert P Brain. 2024; 147(11):3849-3862.

PMID: 38696726 PMC: 11531845. DOI: 10.1093/brain/awae124.


COLQ-Congenital myasthenic syndrome in an Iranian cohort: the clinical and genetics spectrum.

Hesami O, Ramezani M, Ghasemi A, Fatehi F, Okhovat A, Ziaadini B Orphanet J Rare Dis. 2024; 19(1):113.

PMID: 38475910 PMC: 10935773. DOI: 10.1186/s13023-024-03116-x.


Congenital myasthenic syndromes: a retrospective natural history study of respiratory outcomes in a single centre.

Poulos J, Samuels M, Palace J, Beeson D, Robb S, Ramdas S Brain Commun. 2023; 5(6):fcad299.

PMID: 38035366 PMC: 10684295. DOI: 10.1093/braincomms/fcad299.


Molecular Analysis of a Congenital Myasthenic Syndrome Due to a Pathogenic Variant Affecting the C-Terminus of ColQ.

Barbeau S, Semprez F, Dobbertin A, Merriadec L, Roussange F, Eymard B Int J Mol Sci. 2023; 24(22).

PMID: 38003406 PMC: 10671321. DOI: 10.3390/ijms242216217.